Hoe Leong Corporation Ltd. (SGX:H20)

Market Cap	15.14M
Revenue (ttm)	44.01M
Net Income (ttm)	727.00K
Shares Out	15.14B
EPS (ttm)	0.00
PE Ratio	20.83
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	18,821,735
Open	0.0010
Previous Close	0.0010
Day's Range	0.0010 - 0.0010
52-Week Range	0.0010 - 0.0030
Beta	-1.05
RSI	46.80
Earnings Date	Aug 14, 2025

About Ligand Pharmaceuticals

Hoe Leong Corporation Ltd., an investment holding company, designs, manufactures, and distributes heavy equipment parts in Australia, North America, Asia, Europe, the Middle East, and internationally. It operates through Design and Manufacture, and Trading and Distribution segments. The company offers track chains, such as dry sealed and salt chains for bulldozer and excavator models; tracks and carrier rollers; idlers; sprockets and segments; track shoes, including single bar and triple shoes; and crawler shoes. In addition, the company provid...

• Industry: Construction, Mining, And Materials Handling
• Founded: 1957
• Employees: 129
• Stock Exchange: Singapore Exchange
• Ticker Symbol: H20

Financial Performance

In 2024, Hoe Leong Corporation's revenue was 44.01 million, an increase of 9.99% compared to the previous year's 40.01 million. Earnings were 727,000, an increase of 190.80%.